Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
about
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateDecreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous miceTransfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-SynucleinRotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.Synthesis and in vitro evaluation of α-synuclein ligands.A novel strategy for the targeted analysis of protein and peptide metabolitesAltered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.Basic mechanisms of neurodegeneration: a critical update.Synaptic protein alterations in Parkinson's disease.Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.Increased expression of α-synuclein by SNCA duplication is associated with resistance to toxic stimuli.The impairment of learning and memory and synaptic loss in mouse after chronic nitrite exposure.α-synuclein induced synapse damage is enhanced by amyloid-β1-42.α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.The Neuroprotective Effects of Thymoquinone: A Review.
P2860
Q22252904-5A469F5A-8E6F-4390-B205-092AED64CC63Q33715071-136C794E-2CAA-4479-B4D1-B0D7F3111071Q33771253-AA9BA338-B6A3-4507-A41F-789AE662CAB7Q34020622-8412350C-4ACF-4145-AC28-BFEB7D77C588Q34587666-441C6A9E-427F-4E35-BB04-6442B6C7FADCQ34909750-A1FFFF31-D43E-418C-A20E-07DE02CC58E4Q35026876-27F4D756-3DEF-4FF3-94B1-14375AE212A5Q35181537-93C5FD94-5A0B-4DB9-B8EB-864311913B3AQ35894167-9057AB1B-D32F-4C51-9C3D-4DA0988FF210Q36106447-A05CA4D4-E1A5-4677-A517-E65B478962CBQ36112076-9C3C5699-88E8-4CA3-9F1B-ADEF33A189EAQ36336723-8B097783-163D-407F-9826-BB74DA53F50BQ36445937-7799D2E5-FC71-4284-ABE1-9DC9899FE1EEQ37673274-5D4D59BD-4C9E-45E5-BD0D-3D6421BE92ADQ37972089-9FA0F617-8977-4A40-AFCA-A7033503D06DQ38038126-00B9905E-2772-4226-B6AD-13336481D651Q39385017-AAE97E93-1103-4D5E-AFF8-C1627243409BQ41052474-5FEA69BF-9BDE-4F93-BDCD-87921F38F48AQ41670950-2FE18AF8-F892-4E77-8883-A65BEE8F3726Q42111186-DD003AE8-77F5-4DD2-B22D-2DFF40EF84CCQ54936115-7F128B97-0A71-48A0-B083-B0BF89DD6B5C
P2860
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@en
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@nl
type
label
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@en
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@nl
altLabel
Central Role of α-Synuclein Oligomers in Neurodegeneration in Parkinson Disease
@en
prefLabel
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@en
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@nl
P1433
P1476
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
@en
P2093
Aleksey G Kazantsev
Alexander M Kolchinsky
P304
P356
10.1001/ARCHNEUR.65.12.1577
P577
2008-12-01T00:00:00Z